Eddy Pharmaceuticals announced that the company previously planned to acquire a total of 22.2324% of Nanda Pharmaceutical's shares held by Huataixin, DaoXing Venture Capital and Yao Fandi for 130 million yuan. As agreed, the company has paid the final payment of 459.429 million yuan and 231,000 yuan respectively to Huatai Credit and Daoxing Venture Capital, and paid Yao Fandi the full price of 146.25 million yuan, for a total of 160 million yuan. Recently, the settlement of the transaction was completed. Yao Fandi transferred 2.50% of his shares in Nanda Pharmaceutical to the company's name, changed the number of directors of Nanda Pharmaceutical from 10 to 9, and completed the registration of industrial and commercial changes.

Eddy Pharmaceuticals announced that the company previously planned to acquire a total of 22.2324% of Nanda Pharmaceutical's shares held by Huataixin, DaoXing Venture Capital and Yao Fandi for 130 million yuan. As agreed, the company has paid the final payment of 459.429 million yuan and 231,000 yuan respectively to Huatai Credit and Daoxing Venture Capital, and paid Yao Fandi the full price of 146.25 million yuan, for a total of 160 million yuan. Recently, the settlement of the transaction was completed. Yao Fandi transferred 2.50% of his shares in Nanda Pharmaceutical to the company's name, changed the number of directors of Nanda Pharmaceutical from 10 to 9, and completed the registration of industrial and commercial changes.